BCAX Stock-Based Compensation
Bicara Therapeutics Inc · Stock-Based Compensation
BCAX Stock-Based Compensation
Latest reported$8.24Mperiod ending
BCAX Quarterly Stock-Based Comp ($307.50K → $8.24M)
Quarterly stock-based compensation
High-resolution chart · PNG
BCAX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,238,000 | |
| 5,858,000 | |
| 4,449,000 | |
| 3,614,000 | |
| 3,492,000 | |
| 3,451,000 | |
| 3,181,000 | |
| 2,031,000 | |
| 1,038,000 | |
| 1,147,000 | |
| 765,000 | |
| 519,000 | |
| 307,500 | |
| 307,500 |